References
- Sumant SC. Transcriptional regulation of podocyte disease. Transl Res 2007;149:237–242.
- Hohenstein P, Hastie ND. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet 2006;15:R196–201.
- Hammes A, Guo JK, Lutsch G, Leheste JR, Landrock D, Ziegler U, et al. Two splice variants of the Wilms’ tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 2001;106:319–329.
- Wagner N, Wagner KD, Xing Y, Scholz H, Schedl A. The major podocyte protein nephrin is transcriptionally activated by the Wilms’ tumor suppressor WT1. J Am Soc Nephrol 2004;15:3044–3051.
- Kreidberg JA. WT1 and kidney progenitor cells. Organogenesis 2010;6:61–70.
- Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. WT1 is required for early kidney development. Cell 1993;74:679–691.
- Hartwig S, Ho J, Pandey P, Maclsaac K, Taglienti M, Xiang M, Alterovitz G, Ramoni M, Fraenkel E, Kreidberg A. Genomic characterization of Wilms’ tumor suppressor 1 targets in nephron progenitor cells during kidney development. Development 2010;137:1189–1203.
- Dudley AT, Lyons KM, Robertson FJ. A requirement for bone morphogenic protein-7 during development of the mammarian kidney and eye. Genes Dev 1995;9:2795–2807.
- Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G. BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev 1995;9:2808–2820.
- Kazama I, Mahoney Z, Miner HJ, Graf D, Economides AN, Kreidberg JA. 2008. Podocyte-derived BMP-7 is critical for nephron development. J Am Soc Nephrol 19:2181–2191.
- Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 2001;11:1805–1809.
- Ryan G, Steele-Perkins V, Morris JF, Rauscher FJ 3rd, Dressler GR. Repression of PAX-2 by WT1 during normal kidney development. Development 1995;121:867–875.
- Barisoni L, Kriz W, Mundel P, D’Agati V. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999;10:51–61.
- Orloff MS, Iyengar SK, Winkler CA, Goddard KA, Dart RA, Ahuja TS, et al. Variants in the Wilms’ tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics 2005;21:212–221.
- Clement LC, Liu G, Perez-Torres I, Kanwar YS, Avila-Casado C, Chugh SS. Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int 2007; 72:337–347.
- Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437–47.
- Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997;17:467–470.
- Faa G, Gerosa C, Fanni D, Monga G, Zaffanello M, Van Eyken P, Fanos V. Morphogenesis and molecular involved in human kidney development. J Cell Physiol 2011. (In Press).
- Gerosa C, Fanni D, Nemolato S, Locci A, Marinelli V, Cabras T, Messana I, Castagnola M, Monga G, Fanos V, Faa G. Thymosin beta-10 expression in developing human kidney. J Matern Fetal Neonatal Med 2010;23:125–128.
- Smart N, Bollini S, Dubé KN, Vieira JM, Zhou B, Davidson S, Yellon D, Riegler J, Price AN, Lythgoe MF, Pu WT, Riley PR. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011;474:640–644.